Bill > A01445

This bill directs the New York State Commissioner of Health to develop specific rules and regulations for providing state financial reimbursement to municipalities that purchase opioid antagonists. An opioid antagonist (such as naloxone) is a medication that can rapidly reverse an opioid overdose, potentially saving lives. The bill specifically references Article Six of the Public Health Law as the legal framework for these reimbursement rules. The legislation appears aimed at supporting municipal efforts to combat the opioid crisis by helping offset the costs of acquiring life-saving overdose reversal medications. The bill is straightforward in its approach, giving the Commissioner of Health the responsibility to establish the precise details of how municipalities can be reimbursed for these critical medical supplies, and it is set to take effect immediately upon passage.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A1445